Gastric and Gastroesophageal Junction Cancer (DBCOND0123368)
Identifiers
- Synonyms
- Gastric/Gastroesophageal Junction Cancer / Gastric Cancer, Gastroesophageal Junction Cancer / Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) / Gastric or Gastroesophageal Junction Cancer
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05541874 Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03925974 KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer treatment 2 completed NCT03941873 A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) or Gastric/Gastroesophageal Junction Cancer (GC/GEJC) treatment 1 / 2 completed NCT03847168 KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer treatment 1 unknown_status NCT06640153 MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma No drug interventions Not Available Not Available active_not_recruiting NCT02731313 Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma Not Available Not Available completed NCT05246982 HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer treatment 2 unknown_status NCT05942573 Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial treatment 2 recruiting NCT04950322 A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer treatment 3 active_not_recruiting